Horizon Investments, LLC Merck & Co., Inc. Transaction History

Horizon Investments, LLC

$4.32 Billion
Q3 2024

A detailed history of Horizon Investments, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 28,272 shares of MRK stock, worth $2.75 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

28,272

Previous 29,768 5.03%

Holding current value

$2.75 Million

Previous $3.69 Million 12.89%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $166,280 - $192,939	-1,496 Reduced 5.03%	28,272 $3.21 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $3.6 Million - $3.87 Million	-29,111 Reduced 49.44%	29,768 $3.69 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $282,420 - $329,083	2,494 Added 4.42%	58,879 $7.77 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $1.2 Million - $1.31 Million	-12,011 Reduced 17.56%	56,385 $6.15 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $50,857 - $56,479	-494 Reduced 0.72%	68,396 $7.04 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $681,201 - $742,479	-6,272 Reduced 8.34%	68,890 $7.95 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $4.17 Million - $4.65 Million	-40,495 Reduced 35.01%	75,162 $8 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $456,699 - $585,550	5,223 Added 4.73%	115,657 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $1.97 Million - $2.21 Million	23,248 Added 26.66%	110,434 $9.51 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $826,884 - $937,314	9,904 Added 12.82%	87,186 $7.95 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $542,503 - $608,112	7,380 Added 10.56%	77,282 $6.34 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $2.46 Million - $3.08 Million	34,033 Added 94.88%	69,902 $5.36 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $1.69 Million - $1.86 Million	-23,585 Reduced 39.67%	35,869 $2.69 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $250,725 - $277,327	-3,566 Reduced 5.66%	59,454 $4.62 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $4.34 Million - $5.11 Million	63,020 New	63,020 $4.86 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $4.83 Million - $5.36 Million	-67,233 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $10.4 Million - $11.7 Million	-141,472 Reduced 67.79%	67,233 $5.58 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $10.4 Million - $11.8 Million	147,016 Added 238.32%	208,705 $16.1 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $244,316 - $338,633	-3,856 Reduced 5.88%	61,689 $4.75 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $640,578 - $722,817	8,257 Added 14.41%	65,545 $5.96 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $2.8 Million - $3.06 Million	36,858 Added 180.41%	57,288 $4.82 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $1.92 Million - $2.24 Million	-27,508 Reduced 57.38%	20,430 $1.71 Million
Q1 2019 May 16, 2019	BUY	$69.58 - $79.36 $616,826 - $703,526	8,865 Added 22.69%	47,938 $3.99 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $316,805 - $367,647	-4,856 Reduced 11.05%	39,073 $2.99 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $1.58 Million - $1.86 Million	27,348 Added 164.94%	43,929 $3.12 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $36,546 - $42,938	-719 Reduced 4.16%	16,581 $1.01 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $118,125 - $137,295	2,318 Added 15.47%	17,300 $942,000
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $1.07 Million - $1.27 Million	-20,681 Reduced 57.99%	14,982 $952,000
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $2.09 Million - $2.25 Million	35,663	35,663 $2.27 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.

Account

Horizon Investments, LLC Merck & Co., Inc. Transaction History